12:00 AM
May 03, 1999
 |  BC Week In Review  |  Clinical News  |  Regulatory

BioSpecifics regulatory update

BioSpecifics received notice of Good Manufacturing Practices (GMP) violations following an FDA inspection of its facility....

Read the full 59 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >